5 Einträge gefunden

1. Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)

   1. Hambach, Julia
   2. Riecken, Kristoffer
   3. Cichutek, Sophia
   4. Schütze, Kerstin
   5. Albrecht, Birte
   6. Petry, Katharina
   7. Röckendorf, Jana Larissa

   2020 - Forschungsinformationssystem des UKE
2. Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell lines

   1. Nitsch, Emilia
   2. Mina, Sormeh
   3. Brammer, Ingo
   4. Pace, Andrea
   5. Schuch, Gunter
   6. Bokemeyer, Carsten
   7. Zander, Axel

   2014 - Forschungsinformationssystem des UKE
3. Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway

   1. Oliveira Ferrer, Leticia
   2. Wellbrock, Jasmin
   3. Bartsch, Udo
   4. Penas, Eva Maria Murga
   5. Hauschild, Jessica
   6. Klokow, Marianne
   7. Bokemeyer, Carsten

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
4. The metabolite 3-hydroxiglutaric acid effectively reduces glioblastoma growth in vivo by affecting the structural integrity of tumor vasculature.

   1. Oliveira-Ferrer, Leticia
   2. Wellbrock, Jasmin
   3. Balabanov, Melanie
   4. Klockow, Marianne
   5. Hauschild, Jessica
   6. Bokemeyer, Carsten
   7. Fiedler, Walter

   2012 - Forschungsinformationssystem des UKE
5. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.

   1. Bokemeyer, Carsten
   2. Bondarenko, I
   3. Hartmann, J T
   4. de Braud, F
   5. Schuch, Gunter
   6. Zubel, A
   7. Celik, I

   2011 - Forschungsinformationssystem des UKE